Selection of disintegrants for wet granulation method of “Angiolin” tablets
DOI:
https://doi.org/10.14739/2310-1210.2016.5.82698Keywords:
Angiolin, Disintegrants, Tablets, Wet GranulationAbstract
Every year there are about 9.4 million people who die from cardiovascular diseases. Among them, 51% of people are dying from stroke, and 45 % – from coronary heart disease. Today disease of the cardiovascular system is the number 1 problem in the world and in Ukraine. Annually cardiovascular disease kills more than 500 thousands of Ukrainians; it is about 1370 people every day. According to the State Statistics Service, about half of the deaths in 2016 in Ukraine had been caused by cardiovascular diseases. In comparison with 2015, the death rates have not changed in Ukraine. This shows low culture of prevention, diagnosis and treatment of cardiovascular disease among Ukrainians.
Aim of our work is the selection of disintegrants to produce tablets “Angiolin” by wet granulation method with an active compound content of 200 mg.
Materials and methods. 6 Disintegrants have been studied, most of which were presented in market only in recent years and were not used in the pharmaceutical tableting technology.
Results. The disintegrants were studied in the experiment: a1 – potato starch, a2 – croscarmellose sodium, a3 – polyplasdone XL-10, a4 – carboxymethyl starch sodium, a5 – microcrystalline cellulose (MCC) burst, a6 – likotab P. The effect of disintegrants on the technological characteristics of “Angiolin” tablets has been studied and the possibility of their use by wet granulation method has been confirmed.
Conclusion. The selected disintegrant, namely sodium croscarmellose has showed better results and will be used for “Angiolin” tableting by wet granulation method in the future.
References
Bіdnenko, O. S., Kucherenko, L. І., Mazur, І. A., & Moriak, Z. B. (2016) Vybir ratsionalnykh dopomizhnykh rechovyn dlia stvorennia tabletok «Anhiolin» metodom volohoi hranuliatsii [Choice of rational excipients for making tablets «Angiolina» by wet granulation]. Farmatsevtychnyi chasopys, 2(38), 16–21. [in Ukrainian].
Derzhavne pidpryiemstvo «Ukrainskyi naukovyi farmakopeinyi tsentr yakosti likarskykh zasobiv» (2016). Derzhavna Farmakopeia Ukrainy [State Pharmacopoeia of Ukraine]. Kharkiv. [in Ukrainian].
Kovalenko, V. N. (Ed) (2012) Kompendium. Lekarstvennye preparaty 2012 [Compendium. Drugs 2012 ]. Kharkiv. [in Ukrainian].
Hroshovyi, T. A., Martseniuk, V. P., Kucherenko, L. I. (2008) Matematychne planuvannia eksperymentu pry provedenni naukovykh doslidzhen v farmatsii [Mathematical planning experiment in scientific research in pharmacy]. Ternopіl: Ukrmedknyha. [in Ukrainian].
Mazur, I. A., Chekman, I. S., Belenichev, I. F., & Voloshin, N. A. (2007) Metabolitotropnye preparaty [Metabolitotropnye drugs]. Zaporozhzhe. [in Ukrainian].
Mazur, I. A., Belenichev, I. F., Kucherenko, L. I., Bukhtiyarova, N. V., Georgievskij, G. V., Pavlyuk, I. V., & Steblyuk, V. S. (2012) Podkhody k razrabotke i sozdaniyu metabolitotropnyh preparatov – proizvodnykh 1,2,4-triazola [Approaches for development and the creation metabolytotropnыh drugs - 1,2,4-triazole]. Farmakom, 3, 78–82. [in Ukrainian].
Kornatskyi, V. M., Dorohoi, A. P., & Manoilenko, T. S. (2012) Sertsevo-sudynna zakhvoriuvanist v Ukraini ta rekomendatsii shchodo pokrashchannia zdorovia v suchasnykh umovakh [Cardiovascular morbidity in Ukraine and recommendations to improve health in modern conditions]. Analіtychno-statystychnyi posіbnyk. Kyiv. [in Ukrainian].
Kucherenko, L. I., Khromilova, O. V., Moriak, Z. B., Tkachenko, H. I., & Vaschenko, O. V. (2014) Stage control of tablets manufacturing. Current issues in pharmacy and medicine: science and practice, 2, 31–34. [in Ukrainian].
Andersson, B., Strömblad, S. O., Lomsky, M., & Waagstein, F. (1999). Heart rate dependency of cardiac performance in heart failure patients treated with metoprolol. Eur. Heart. J, 20, 575– 580.
(2007) European Pharmacopoeia. Сouncil of Europe. Strasbourg.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)